IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Orexigen Therapeutics Inc

CUSIP: 686164904 | 8 institutional holders

Quarters

Q2 2016Q1 2016Q4 2015Q3 2015Q2 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile